Making best practice, everyday practice

Login Register

How to use insulin glargine U300 in everyday clinical practice?

Real-world evidence from KANTAR and DELIVER-2 shows use of Gla-300 in T2DM is significantly associated with lowered daily basal insulin dose requirements, lower HbA1c and fewer hypoglycaemic events. Case studies highlight these advantages.

Read below to complete the CPD questions

 

CLICK ABOVE TO READ THE REPORT
WATCH THE ACCREDITED VIDEO AND READ THE SUMMARY REPORT

Do you like this? Share with a colleague